Product Information
CEVIMELINE HCL 30 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.6871 per EA under NDC 59651042201. Its NADAC has been published 147 times since Sep 6, 2023.
Strength
30 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651042201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEVIMELINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215056On Market Since
4/18/2023
Pharmacological Classes
Price Statistics
The NADAC for CEVIMELINE HCL 30 MG CAPSULE has been published 147 times since Sep 6, 2023, and over the history we have for it it has declined 43.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6871 per EA |
|---|---|
| All-time high | $1.2078 (Sep 13, 2023) |
| All-time low | $0.6268 (Nov 20, 2024) |
| 52-week high | $0.7172 |
| 52-week low | $0.6572 |
| Median price | $0.7172 |
| Average price | $0.8256 |
| Largest weekly change | -27.7% (Nov 20, 2024) |
| Weeks tracked | 147 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEVIMELINE HCL 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEVIMELINE HCL 30 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.6871 per EA (NDC 59651042201), effective Jun 24, 2026.
How has the price of CEVIMELINE HCL 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEVIMELINE HCL 30 MG CAPSULE has declined 43.1%. It has been tracked across 147 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for CEVIMELINE HCL 30 MG CAPSULE?
Since Sep 6, 2023, the NADAC for CEVIMELINE HCL 30 MG CAPSULE has ranged from a low of $0.6268 (Nov 20, 2024) to a high of $1.2078 (Sep 13, 2023), with a median of $0.7172 per EA.
Are there cheaper alternatives to CEVIMELINE HCL 30 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CEVIMELINE HCL 30 MG CAPSULE, but none are currently priced below it.
Who manufactures CEVIMELINE HCL 30 MG CAPSULE?
CEVIMELINE HCL 30 MG CAPSULE (NDC 59651042201) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification